Influence of conjugation of doxorubicin to transferrin on the iron uptake by K562 cells via receptor‐mediated endocytosis

European Journal of Biochemistry

Volumn 213, Issue 1, 1993, Pages 427-436

  BÉRCZI, Alajos ^a   RUTHNER, Monika ^b   SZŰTS, Viktória ^a   FRITZER, Monika ^b   SCHWEINZER, Esther ^b   GOLDENBERG, Hans ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE; DOXORUBICIN; THIOL GROUP; TRANSFERRIN;

ARTICLE; CELL MEMBRANE; CONJUGATION; ENDOCYTOSIS; HUMAN; HUMAN CELL; IRON TRANSPORT; LEUKEMIA CELL; MEMBRANE FLUIDITY; PRIORITY JOURNAL;

DOXORUBICIN; ENDOCYTOSIS; HUMAN; IRON; RECEPTORS, TRANSFERRIN; SUPPORT, NON-U.S. GOV'T; TRANSFERRIN; TUMOR CELLS, CULTURED;

EID: 0027447437     PISSN: 00142956     EISSN: 14321033     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1993.tb17778.x     Document Type: Article

References (51)

1. Identification of transferrin receptor on the surface of human cultured cells
2. Transferrin and transferrin receptors in carcinoma of the breast
3. Transferrin binding by human lymphoblastoid cell lines and other transformed cells
4. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin
5. Transferrin and iron uptake by human lymphoblastoid and K562 cells
6. Heterogeneity of the human transferrin receptor and the use of anti‐transferrin receptors antibodies to detect tumours in vivo
7. Transferrin receptor growth control in normal and abnormal cells
8. Targeting of cytotoxic drug by transferrin receptors: selective killing of acute myelogenous leukemia cells
9. A highly cytotoxic human transferrin‐ricin A chain conjugate used to select receptor modified cells
10. Characterization of a transferrin‐diphtheria toxin conjugate
11. Kinetics of internalization and cytotoxicity of transferrin‐neocarzinostatin conjugate in human leukemia cell line, K562
12. Uptake and concentration of bioactive macromolecules by K562 cells via the transferrin cycle utilizing an acid‐labile transferrin conjugate
13. Cytotoxicity of a transferrin‐adriamycin conjugate to anthracydcline‐resistant cells
14. Preliminary clinical study of transferrin‐adriamycin conjugates for drug delivery to acute leukemia patients
15. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome
16. Demonstration of two distinct transferrin receptor recycling pathways and transferrin‐independent receptor inernalization in K562 cells
17. Protein and cell membrane iodination with a sparingly soluble chloroamide 1,3,4,6‐tetrachloro‐3α,6α‐diphenylglycoluril
18. The reaction of ferric salts with transferrin
19. 2‐transferrin reductase and iron uptake in K562 cells are not directly related
20. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein‐dye binding
21. Receptor‐mediated endocytosis of transferrin in K562 cells
22. The structure, function, and regulation of transferrin receptor
23. A rapid redistribution of transferrin receptor to the cell surface of HL‐60 cells and K562 cells upon treatment with dimethyl sulfoxide due to slowing of endocytosis
24. Reconstitution of transferrin receptor in mixed lipid vesicles. An example of the role of elastic and electrostatic forces for protein/lipid assembly
25. Characterization of the cooperative cross‐linking of doxorubicin N‐hydroxysuccinimide ester derivatives to water soluble proteins
26. Iron transport and storage proteins
27. Effects of benzyl alcohol on transferrin and low density lipoprotein receptor mediated endocytosis in leukemic guinea pig B lymphocytes
28. The release of iron and transferrin from the human melanoma cell
29. Receptor‐mediated endocytosis of transferrin and uptake of Fe in K562 cells: identification of a nonlysosomal acidic compartment
30. Co‐migration and internalization of transferrin and its receptor on K562 cells
31. Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: an equilibrium binding study
32. Evidence of a specific complex between adriamycin and negatively‐charged phospholipids
33. Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites
34. Transverse location of anthracyclines in lipid bilayers. Paramagnetic quenching studies
35. Cell surface actions of adriamycin
36. Oxidative destruction of erythrocyte ghost membranes catalyzed by the doxorubicin‐iron complex
37. The effect of anasthetics on protein conformation in membranes as studied by the spin‐labelling technique
38. Lipid–protein interaction in frog nerve membrane as studied by spin‐labelling
39. Plasma membrane redox reactions involved in signal transduction
40. Transferrin receptor internalization sequence YXRF implicates a tight turn as the structural recognition motif for endoctosis
41. Sorting of endocytosed transferrin and asialoglycoprotein occurs immediately after internalization in HepG2 cells
42. Iterative fractionation of recycling receptors from lysosomally destined ligands in an early sorting endosome
43. Coated endosomal vesicles. Sorting and recycling compartment for transferrin in BHK cells
44. Reduction of ribonucleotides
45. Recent advances in cancer research: drug targeting without the use of monoclonal antibodies
46. Transferrin‐adriamycin conjugates which inhibit tumor cell proliferation without intercalation with DNA inhibit plasma membrane oxidoreductase and proton release in K562 cells
47. Inhibition of transplasma membrane electron transport by transferrin‐adriamycin conjugates
48. Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA
49. Cell surfacemediated cytotoxicity of polymer‐bound adriamycin against drug‐resistant hepatocytes
50. Cell surface effects of adriamycin and carminomycin immobilized on cross‐linked polyvinyl alcohol
51. Induction of erythroid differentiation in human leukemic K562 cells by membrane directed action of adriamycin covalently bound to microspheres